Amendment No. 1 to Employment Agreement between ICN Pharmaceuticals, Inc. and Richard A. Meier

Summary

ICN Pharmaceuticals, Inc. and Richard A. Meier have agreed to amend their original employment agreement dated December 31, 1998. This amendment updates the position title for Mr. Meier to Executive Vice President - Chief Financial Officer or another senior executive role as mutually agreed in writing. All other terms of the original agreement remain unchanged. The amendment was executed on April 14, 2000.

EX-10.35 6 a69091ex10-35.txt EXHIBIT 10.35 1 EXHIBIT 10.35 AMENDMENT NO. 1 EMPLOYMENT AGREEMENT WHEREAS, ICN Pharmaceuticals, Inc. (the "Company") and Richard A. Meier (the "Executive") entered into an Employment Agreement (the "Agreement") dated December 31, 1998; WHEREAS, the Company and the Executive now desire to amend the Agreement; NOW, THEREFORE, in consideration of the respective agreements of the parties contained herein, it is agreed as follows: Paragraph 2(a) - The first sentence shall be deleted in its entirety and should now read as follows: The Executive shall be employed as the Executive Vice President - Chief Financial Officer of the Company or such other senior executive capacity as may be mutually agreed to in writing by the parties. All other provisions of the Agreement remain in full force and effect. Executed this 14th day of April, 2000. ICN Pharmaceuticals, Inc. ATTEST: By: ---------------------------------------- Title: David C. Watt Executive Vice President, General Counsel and Corporate Secretary - --------------------------- The "Executive" By: ----------------------------------------- Richard A. Meier 1